OUR IMPACT: 2019 OUR IMPACT: 2019 A Year In Review 2019 was a year of growth, inspiration and tenacity. We set out to make significant research and awareness investments, grow our support programs, and further our partnerships to deliver services and...
Promising Treatment for Deadly Cancer Blocked by Canadian Regulators See original press release on Newswire TORONTO, Aug. 19, 2020 /CNW Telbec/ – While innovations in health care are spurring extraordinary advances in the treatment of malignant tumours,...
Community fundraiser adapts amidst global pandemic By Ali Schofield Dedicated. Resilient. Compassionate. These are just a few words that describe Pam Kosolofski, a steadfast champion of progress for pancreatic cancer patients – even amidst a global pandemic. Each...
For several months the COVID-19 crisis has caused many research projects to slow, but Pancreatic Cancer Canada’s research program has not been idle. We have taken this time to quietly prepare for our next big project, because even in the midst of...
Pancreatic Cancer Clinical Trial Launches During Pandemic With Aim to Change Standard of Care for Patients TORONTO, ON, July 15, 2020 – Pancreatic Cancer Canada announced today the launch of NeoPancONE, a Phase II clinical trial that aims to be a curative strategy for...
Recent Comments